Log in

NASDAQ:TLRYTilray Stock Price, Forecast & News

$7.76
-0.35 (-4.32 %)
(As of 08/6/2020 04:00 PM ET)
Add
Compare
Today's Range
$7.72
Now: $7.76
$8.13
50-Day Range
$6.96
MA: $7.68
$8.70
52-Week Range
$2.43
Now: $7.76
$46.25
Volume5.28 million shs
Average Volume9.13 million shs
Market Capitalization$968.92 million
P/E RatioN/A
Dividend YieldN/A
Beta3.16
Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Nanaimo, Canada.
Read More
Tilray logo

Beat the Market (BTM) Rank

Analyst Opinion: 4.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.39 out of 5 stars


Industry, Sector and Symbol

Industry Medicinals & botanicals
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:TLRY
CUSIPN/A
CIKN/A
Phone206-432-9325

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$166.98 million
Book Value$2.78 per share

Profitability

Net Income$-321,170,000.00
Net Margins-241.79%

Miscellaneous

Employees1,646
Market Cap$968.92 million
Next Earnings Date8/10/2020 (Confirmed)
OptionableOptionable
$7.76
-0.35 (-4.32 %)
(As of 08/6/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive TLRY News and Ratings via Email

Sign-up to receive the latest news and ratings for TLRY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Tilray (NASDAQ:TLRY) Frequently Asked Questions

How has Tilray's stock been impacted by COVID-19 (Coronavirus)?

Tilray's stock was trading at $7.09 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, TLRY shares have increased by 9.4% and is now trading at $7.76.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of Tilray?

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tilray in the last year. There are currently 2 sell ratings, 11 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Tilray
.

When is Tilray's next earnings date?

Tilray is scheduled to release its next quarterly earnings announcement on Monday, August 10th 2020.
View our earnings forecast for Tilray
.

How can I listen to Tilray's earnings call?

Tilray will be holding an earnings conference call on Monday, August 10th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Tilray's earnings last quarter?

Tilray Inc (NASDAQ:TLRY) issued its earnings results on Monday, May, 11th. The company reported ($1.73) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.44) by $1.29. The business earned $52.20 million during the quarter, compared to analyst estimates of $49.37 million. Tilray had a negative return on equity of 62.82% and a negative net margin of 241.79%. The company's quarterly revenue was up 127.0% compared to the same quarter last year. During the same quarter in the prior year, the company earned ($0.27) earnings per share.
View Tilray's earnings history
.

What price target have analysts set for TLRY?

15 brokerages have issued 1-year target prices for Tilray's stock. Their forecasts range from $4.00 to $31.00. On average, they expect Tilray's stock price to reach $12.77 in the next year. This suggests a possible upside of 64.6% from the stock's current price.
View analysts' price targets for Tilray
.

Has Tilray been receiving favorable news coverage?

News headlines about TLRY stock have been trending somewhat positive this week, according to InfoTrie Sentiment Analysis. InfoTrie scores the sentiment of media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Tilray earned a media sentiment score of 1.0 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next few days.
View the latest news about Tilray
.

Who are some of Tilray's key competitors?

What other stocks do shareholders of Tilray own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tilray investors own include Canopy Growth (CGC), Cronos Group (CRON), Aurora Cannabis (ACB), NVIDIA (NVDA), Alibaba Group (BABA), Micron Technology (MU), Netflix (NFLX), Advanced Micro Devices (AMD), Aphria (APHA) and Square (SQ).

Who are Tilray's key executives?

Tilray's management team includes the following people:
  • Mr. Edward Wood Pastorius Jr., Chief Revenue Officer (Age 50)
  • Mr. Brendan Kennedy, Pres, CEO & Director (Age 46)
  • Mr. Mark Castaneda, CFO, Sec. & Treasurer (Age 53)
  • Dr. Catherine Jacobson, Director of Clinical Research & Member of Medical Advisory Board

When did Tilray IPO?

(TLRY) raised $135 million in an initial public offering (IPO) on Thursday, July 19th 2018. The company issued 9,000,000 shares at $14.00-$16.00 per share. Cowen and Company acted as the underwriter for the IPO and Roth Capital Partners and Northland Securities were co-managers.

What is Tilray's stock symbol?

Tilray trades on the NASDAQ under the ticker symbol "TLRY."

Who are Tilray's major shareholders?

Tilray's stock is owned by many different retail and institutional investors. Top institutional shareholders include Stelac Advisory Services LLC (0.05%), Swiss National Bank (0.05%), Leap Investments LP (0.02%), Wedbush Securities Inc. (0.02%), Exane Derivatives (0.01%) and AdvisorShares Investments LLC (0.01%). Company insiders that own Tilray stock include Brendan Kennedy, Christine StClare, Edward Wood Pastorius Jr, Mark Castaneda and Michael Auerbach.
View institutional ownership trends for Tilray
.

Which major investors are selling Tilray stock?

TLRY stock was sold by a variety of institutional investors in the last quarter, including AdvisorShares Investments LLC. Company insiders that have sold Tilray company stock in the last year include Brendan Kennedy, and Michael Auerbach.
View insider buying and selling activity for Tilray
.

Which major investors are buying Tilray stock?

TLRY stock was purchased by a variety of institutional investors in the last quarter, including Leap Investments LP, Wedbush Securities Inc., Swiss National Bank, Aua Capital Management LLC, National Asset Management Inc., Stelac Advisory Services LLC, IFP Advisors Inc, and Exane Derivatives.
View insider buying and selling activity for Tilray
.

How do I buy shares of Tilray?

Shares of TLRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Tilray's stock price today?

One share of TLRY stock can currently be purchased for approximately $7.76.

How big of a company is Tilray?

Tilray has a market capitalization of $968.92 million and generates $166.98 million in revenue each year. The company earns $-321,170,000.00 in net income (profit) each year or ($1.69) on an earnings per share basis. Tilray employs 1,646 workers across the globe.

What is Tilray's official website?

The official website for Tilray is www.tilray.com.

How can I contact Tilray?

Tilray's mailing address is 1100 MAUGHAN ROAD, NANAIMO A1, V9X 1J2. The company can be reached via phone at 206-432-9325.

This page was last updated on 8/7/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.